Novo Nordisk is represented by E. Paige Sensenbrenner and Diana Cole Surprenant of Adams & Reese LLP and Loren Brown of DLA Piper LLP.
Eli Lilly & Co. is represented by Christopher P. Ieyoub of Plauche Smith & Nieset LLC and James F. Hurst PC, Renee D. Smith, and Diana M. Watral of Kirkland & Ellis LLP.
